COVID-19: MENARINI, NUOVO REAGENTE MADE IN ITALY PER ISOLARE L’RNA VIRALE

Menarini Diagnostics acquisisce il ramo d’azienda di EOS e rafforza la sua presenza nel mercato della Preanalitica e Point Of Care.

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

German Minister of Health Jens Spahn receives briefing on Menarini Diagnostics fast and reliable COVID VitaPCR® POC instrument.